# Riluzole in Fragile X Syndrome

> **NCT00895752** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 6 (actual)

## Conditions studied

- Fragile X Syndrome

## Interventions

- **DRUG:** Riluzole

## Key facts

- **NCT ID:** NCT00895752
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895752, "Riluzole in Fragile X Syndrome". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00895752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*